Abstract: Fatty liver disease, also known as hepatic steatosis, is a prevalent condition where fat accumulates within liver cells. Determining the severity of hepatic steatosis is crucial for guiding ...

Background Interferon (IFN)-stimulated gene 15 (ISG15) is a downstream molecule of the IFN pathways central to many cellular processes. ISG15 mainly exerts its function through a post-translational ...

Myocardial infarction is a major disease that seriously jeopardizes human health, and patients with comorbid metabolic disorders usually have a faster progression and worse prognosis. The presence of ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Lysophosphatidylinositol (LPI) bioactive ...

Abstract: Ultrasound (US) is considered a key modality for the clinical assessment of hepatic steatosis (i.e., fatty liver) due to its noninvasiveness and availability. Deep learning methods have ...

Shown are the genetic variants identified in EPO, the gene encoding erythropoietin (EPO), in patients with erythrocytosis. The term cDNA denotes complementary DNA, F female, M male, and NA not ...

Early hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS) insertion, especially within the first 30 days, was associated with reduced survival in patients with liver ...

Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024 Extended pre-clinical, clinical and IP package includes FDA and EMA orphan drug and ...

Objective: To explore the connection between metabolic parameters and the severity of hepatic steatosis determined through ultrasound in elderly individuals with metabolic dysfunction-associated fatty ...